Susquehanna International Group, LLP Allakos Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Allakos Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 489,426 shares of ALLK stock, worth $161,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,426

Previous 576,472 15.1%

Holding current value

$161,510

Previous $697,000 83.93%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.23 - $1.24 $20,020 - $107,937	-87,046 Reduced 15.1%	489,426 $112,000
Q4 2024 Feb 14, 2025	BUY	$0.62 - $1.5 $247,223 - $598,122	398,748 Added 224.36%	576,472 $697,000
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.92 $48,690 - $82,953	90,167 Added 102.98%	177,724 $115,000
Q2 2024 Aug 15, 2024	BUY	$1.0 - $1.45 $48,324 - $70,069	48,324 Added 123.17%	87,557 $87,000
Q1 2024 May 07, 2024	SELL	$1.02 - $3.23 $101,888 - $322,647	-99,891 Reduced 71.8%	39,233 $49,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $550,886 - $1.02 Million	-320,283 Reduced 69.72%	139,124 $379,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $236,072 - $615,117	110,832 Added 31.8%	459,407 $1.04 Million
Q2 2023 Aug 11, 2023	SELL	$3.6 - $5.25 $2.15 Million - $3.13 Million	-596,671 Reduced 63.12%	348,575 $1.52 Million
Q1 2023 May 16, 2023	BUY	$4.3 - $8.27 $947,165 - $1.82 Million	220,271 Added 30.38%	945,246 $4.21 Million
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $3.76 Million - $5.6 Million	664,675 Added 1102.28%	724,975 $6.1 Million
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $43,321 - $87,791	-14,345 Reduced 19.22%	60,300 $369,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $61,804 - $145,953	-23,771 Reduced 24.15%	74,645 $234,000
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $880,714 - $1.7 Million	-173,369 Reduced 63.79%	98,416 $561,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $1.73 Million - $22.6 Million	202,337 Added 291.35%	271,785 $2.66 Million
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $3.76 Million - $5.42 Million	49,073 Added 240.85%	69,448 $7.35 Million
Q2 2021 Aug 11, 2021	BUY	$85.37 - $114.1 $1.29 Million - $1.72 Million	15,077 Added 284.58%	20,375 $1.74 Million
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $56,510 - $79,134	-515 Reduced 8.86%	5,298 $608,000
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $344,342 - $659,651	-4,327 Reduced 42.67%	5,813 $814,000
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $9,565 - $13,102	-144 Reduced 1.4%	10,140 $826,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $118,071 - $216,329	-2,681 Reduced 20.68%	10,284 $739,000
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $399,475 - $838,548	-8,979 Reduced 40.92%	12,965 $577,000
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $152,458 - $441,292	4,918 Added 28.89%	21,944 $1.73 Million
Q2 2019 Aug 16, 2019	BUY	$36.0 - $44.73 $612,936 - $761,572	17,026 New	17,026 $738,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

52.3M

Call Options Held

71.5K

Put Options Held

19.8K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $28M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Allakos Inc. Transaction History